Glow Lifetech Corp. is a Health Care company. Its directors and officers file their transactions with SEDI. In the past year (24 October 2025 to 24 October 2026), 11 filings came from 6 insiders.
Not one open-market sale was filed. On the buying side, 4 insiders reported 4 purchases totalling €9,240. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €3,061 from Carducci, Roberto Paolo, disclosed on 28 August 2026, or 0.057% of market capitalisation. Among those who bought: 4 senior executives.
The most recent open-market purchase was published on 28 August 2026, 58 days ago. Filings reach the SEDI feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
For context, the typical company on the same exchange (median of 2,734 companies) published 14 filings over the same period, against 11 filings here. Our records for Glow Lifetech Corp. go back to 2024, with 4 purchases and no sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
21 of 21 declarations
Glow Lifetech Corp. is a company listed on the Toronto Stock Exchange, specializing in the development of innovative health technologies. It focuses on enhancing quality of life through advanced technological solutions.